Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin.

Abstract:

:Surface receptors specific for either the C4b (CR1) or C3d (CR2) component of complement were examined on the neoplastic cells from 30 cases of non-Hodgkin's lymphoma of B-cell origin and on cells derived from 9 normal lymphoid tissues. Lymphocyte suspensions from non-neoplastic peripheral blood, tonsils, and lymph node contained three categories of complement receptor lymphocytes (CRL): cells with receptors for both C4b and C3d (CR1+, CR2+); cells with receptors for C4b but not C3d (CR1+, CR2-), and cells with receptors for C3d but not C4b (CR1-, CR2+). The mean of the proportion of total CRL expressing receptors only of C3d (CR1-, CR2+) was 0.35 for non-neoplastic tissues and 0.28 for malignant lymphomas of follicular center cell (FCC) origin. However, the proportion of cells with this phenotype was significantly higher in well differentiated lymphocytic lymphomas (WDL) and chronic lymphocytic leukemia (CLL) (0.65) and in intermediately differentiated lymphocytic lymphomas (IDL) (0.59). Histologic compartmentalization of the CRL subtypes was observed in frozen sections of normal lymphoid tissue. CR1+ cells were present in lymphoid follicles interfollicular areas, and in splenic red pulp. CR2+ cells were confined to lymphoid follicles. These findings strongly suggest that complement receptor phenotypes may be useful markers of B-cell differentiation.

journal_name

Blood

journal_title

Blood

authors

Cossman J,Jaffe ES

subject

Has Abstract

pub_date

1981-07-01 00:00:00

pages

20-6

issue

1

eissn

0006-4971

issn

1528-0020

journal_volume

58

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.

    abstract::Between 1990 and 1996, we conducted a randomized trial in adults with newly diagnosed acute myeloid leukemia (AML) in order to compare relapse-free interval (RFI) after double induction (arm B), timed-sequential induction (arm C), or control "3 + 7" induction (arm A). Patients achieving complete remission (CR) after i...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2003-10-3561

    authors: Castaigne S,Chevret S,Archimbaud E,Fenaux P,Bordessoule D,Tilly H,de Revel T,Simon M,Dupriez B,Renoux M,Janvier M,Micléa JM,Thomas X,Bastard C,Preudhomme C,Bauters F,Degos L,Dombret H

    更新日期:2004-10-15 00:00:00

  • Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

    abstract::MCL-1 is a Bcl-2 family member that has been described as antiapoptotic in various myeloid neoplasms. Therefore, MCL-1 has been suggested as a potential new therapeutic target. Systemic mastocytosis (SM) is a myeloid neoplasm involving mast cells (MCs) and their progenitors. In the present study, we examined the expre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-032714

    authors: Aichberger KJ,Mayerhofer M,Gleixner KV,Krauth MT,Gruze A,Pickl WF,Wacheck V,Selzer E,Müllauer L,Agis H,Sillaber C,Valent P

    更新日期:2007-04-01 00:00:00

  • Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression.

    abstract::CD56(high) acute myeloid leukemias (AMLs) have a poor prognosis, but it has been unclear how CD56 expression is controlled and how it relates to clinical aggressiveness. We show that CD56 expression on AML cells correlates with an abnormal expression pattern of runt-related transcription factor 1 (RUNX1) isoforms. Whe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-074203

    authors: Gattenloehner S,Chuvpilo S,Langebrake C,Reinhardt D,Müller-Hermelink HK,Serfling E,Vincent A,Marx A

    更新日期:2007-09-15 00:00:00

  • Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells.

    abstract::Studies in mice have shown that proinflammatory Th17 cells can cause acute graft-versus-host disease (aGVHD) related tissue damage; however, whether they play a role in human aGVHD remains unclear. In a prospective study, we measured the proportion of Th17 cells in the blood and skin of patients at the onset of aGVHD....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-295436

    authors: Broady R,Yu J,Chow V,Tantiworawit A,Kang C,Berg K,Martinka M,Ghoreishi M,Dutz J,Levings MK

    更新日期:2010-12-16 00:00:00

  • An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.

    abstract::Although combination regimens have improved outcomes over monotherapy in chronic lymphocytic leukemia (CLL), patients eventually relapse. Combined fludarabine, cyclophosphamide, and monoclonal anti-CD52 antibody alemtuzumab (FCC) provided synergistic cytotoxicity with effective clearing of minimal residual disease. Th...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-05-351833

    authors: Montillo M,Tedeschi A,Petrizzi VB,Ricci F,Crugnola M,Spriano M,Spedini P,Ilariucci F,Uziel L,Attolico I,Vismara E,De Blasio A,Zaccaria A,Morra E

    更新日期:2011-10-13 00:00:00

  • AIDS, T cells, chemotherapy: HAART-breaking?

    abstract::Chemotherapy depletes T cells in AIDS patients on HAART, but preexisting lymphopenia limits the scale compared with non-AIDS patients. Thus T-cell recovery time to baseline may be rapid, but the risk of additional AIDS-related complications persists. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2008-01-134528

    authors: Little RF

    更新日期:2008-04-15 00:00:00

  • Mutations of the ras proto-oncogenes in childhood monosomy 7.

    abstract::ras gene mutations are the most frequent molecular changes found in the preleukemic syndromes of adults and may play a role in initiating these diseases and in their progression to acute leukemia. However, little is known about the incidence or importance of these genetic mutations in childhood myeloproliferative stat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Neubauer A,Shannon K,Liu E

    更新日期:1991-02-01 00:00:00

  • Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.

    abstract::Congenital erythropoietic porphyria (CEP) is an autosomal recessive disorder of heme synthesis characterized by reduced activity of uroporphyrinogen III synthase and the accumulation of nonphysiologic isomer I porphyrin metabolites, resulting in ineffective erythropoiesis and devastating skin photosensitivity. Managem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-584664

    authors: Egan DN,Yang Z,Phillips J,Abkowitz JL

    更新日期:2015-07-09 00:00:00

  • The effect of recombinant erythropoietin on intracellular free calcium in erythropoietin-responsive cells.

    abstract::We have investigated whether recombinant erythropoietin (r-Epo) elicits a change in intracellular free calcium (IFC) in purified Epo-responsive cells in spleens of mice treated with phenylhydrazine. Colony-forming units (CFU-E) were prepared by negative selection through immunologic panning. Anti-Forssman, Mac-1, Ia, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Imagawa S,Smith BR,Palmer-Crocker R,Bunn HF

    更新日期:1989-05-01 00:00:00

  • A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling.

    abstract::Platelets contain and release several matrix metalloproteinases (MMPs). Among these, active MMP-2 enhances platelet aggregation by favoring the activation of phosphatidylinositol 3- kinase (PI3K) and contributes to arterial thrombosis. The platelet surface target of MMP-2 and the mechanism through which it primes plat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-724245

    authors: Sebastiano M,Momi S,Falcinelli E,Bury L,Hoylaerts MF,Gresele P

    更新日期:2017-02-16 00:00:00

  • BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma.

    abstract::Follicular lymphoma (FL) is characterized by a relatively indolent clinical course, but the disease often transforms into a more aggressive large cell lymphoma with a rapidly progressive clinical course. In the present study, we analyzed 41 cases of FL known to have subsequently transformed to aggressive lymphoma and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2482

    authors: Akasaka T,Lossos IS,Levy R

    更新日期:2003-08-15 00:00:00

  • Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).

    abstract::Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia in which venous thrombosis is the most common cause of death. Here we address the risk factors for thrombosis and the role of warfarin prophylaxis in PNH. The median follow-up of 163 PNH patients was 6 years (range, 0.2-38 years). Of the patient...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0009

    authors: Hall C,Richards S,Hillmen P

    更新日期:2003-11-15 00:00:00

  • Distinct HLA associations by stroke subtype in children with sickle cell anemia.

    abstract::Children with sickle cell anemia (SCA) carry a 200-fold increased risk for cerebral infarction. Stroke can be the result of small-vessel (SV) or large-vessel (LV) disease. However, it is unknown whether these subtypes result from the same pathophysiologic processes. Complete HLA genotyping was performed on 231 eligibl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2002-09-2791

    authors: Hoppe C,Klitz W,Noble J,Vigil L,Vichinsky E,Styles L

    更新日期:2003-04-01 00:00:00

  • Expression of ABH and X (Lex) antigens on platelets and lymphocytes.

    abstract::We used a panel of reagents, polyclonal and monoclonal antibodies, and lectins to define the expression of the ABH- and Lewis-related specificities on platelets and lymphocytes. We also determined the expression of the alpha 2- and alpha 3-L-fucosyltransferases necessary for their biosynthesis. The antigens that could...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mollicone R,Caillard T,Le Pendu J,François A,Sansonetti N,Villarroya H,Oriol R

    更新日期:1988-04-01 00:00:00

  • Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients.

    abstract::There is evidence from bone marrow transplantation that T cells may be involved in the immunologic control of leukemia. But many patients relapse despite a potent graft-versus-leukemia effect mediated by allogeneic T cells. The expression of the FasL protein has been suggested as a mechanism of tumor immune escape. We...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Buzyn A,Petit F,Ostankovitch M,Figueiredo S,Varet B,Guillet JG,Ameisen JC,Estaquier J

    更新日期:1999-11-01 00:00:00

  • The protein C activator AB002 rapidly interrupts thrombus development in baboons.

    abstract::Although thrombin is a key enzyme in the coagulation cascade and is required for both normal hemostasis and pathologic thrombogenesis, it also participates in its own negative feedback via activation of protein C, which downregulates thrombin generation by enzymatically inactivating factors Va and VIIIa. Our group and...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood.2019002771

    authors: Tucker EI,Verbout NG,Markway BD,Wallisch M,Lorentz CU,Hinds MT,Shatzel JJ,Pelc LA,Wood DC,McCarty OJT,Di Cera E,Gruber A

    更新日期:2020-02-27 00:00:00

  • Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.

    abstract::The intestinal microbiota in allogeneic bone marrow transplant (allo-BMT) recipients modulates graft-versus-host disease (GVHD), a systemic inflammatory state initiated by donor T cells that leads to colitis, a key determinant of GVHD severity. Indole or indole derivatives produced by tryptophan metabolism in the inte...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-03-838193

    authors: Swimm A,Giver CR,DeFilipp Z,Rangaraju S,Sharma A,Ulezko Antonova A,Sonowal R,Capaldo C,Powell D,Qayed M,Kalman D,Waller EK

    更新日期:2018-12-06 00:00:00

  • Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cells.

    abstract::Soluble thrombomodulin plasma concentrations are elevated in steroid-resistant graft-versus-host disease (GVHD), implying endothelial hypofunctioning for thrombomodulin-dependent generation of activated protein C's (APC) anticoagulant, anti-inflammatory, and antiapoptotic functions. Recombinant thrombomodulin or APC a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001259

    authors: Sinha RK,Flynn R,Zaiken M,Paz K,Gavin AL,Nemazee D,Fernández JA,Xu X,Griffin JH,Blazar BR

    更新日期:2019-08-29 00:00:00

  • In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.

    abstract::Expression of B7 family costimulatory molecules on B cells defines their capacity to function as antigen presenting cells (APCs). B cells that do not express B7 costimulatory molecules induce T-cell tolerance. Therefore, the expression of B7 costimulatory molecules on malignant B cells might be critical for their reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dorfman DM,Schultze JL,Shahsafaei A,Michalak S,Gribben JG,Freeman GJ,Pinkus GS,Nadler LM

    更新日期:1997-12-01 00:00:00

  • Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.

    abstract::The bcr1- and bcr3- promyelocytic leukemia/retinoic acid receptor alpha (PML/RAR alpha) are the two major fusion proteins expressed in acute promyelocytic leukemia (APL) patients. These proteins, which are present in different lengths of PML (amino acids 1-552 and 1-394, respectively), contain most of the functional d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Benedetti L,Levin AA,Scicchitano BM,Grignani F,Allenby G,Diverio D,Lo Coco F,Avvisati G,Ruthardt M,Adamo S,Pelicci PG,Nervi C

    更新日期:1997-08-01 00:00:00

  • Notes from the Director, National Heart, Lung, and Blood Institute: transitions.

    abstract::During this time of transition in the federal government and the National Institutes of Health, I write to assure the Blood community of the National Heart, Lung, and Blood Institute's (NHLBI) commitment to new and established investigators as outlined in the NHLBI Strategic Plan. This perspective discusses the NHLBI ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-194100

    authors: Nabel EG

    更新日期:2009-03-26 00:00:00

  • Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.

    abstract::Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) was performed in non-Hodgkin's lymphoma (NHL), which is known to be highly responsive to chemotherapy, but also yields variable treatment results to answer the following questions: (1) What is the extent and time course of changes in FDG utilizatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Römer W,Hanauske AR,Ziegler S,Thödtmann R,Weber W,Fuchs C,Enne W,Herz M,Nerl C,Garbrecht M,Schwaiger M

    更新日期:1998-06-15 00:00:00

  • Regulation of monocyte procoagulant by chemoattractants.

    abstract::Various n-formylated peptides function as receptor-specific chemoattractants for both granulocytes and monocytes. Because these agents are important tools in the study of leukocyte function in vitro, we chose to examine their effects on leukocyte procoagulant activity. The synthetic chemotactic peptide N-formyl-methio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Janco RL,Morris PJ

    更新日期:1985-03-01 00:00:00

  • Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.

    abstract::One hundred seventy-nine patients with acute nonlymphoblastic leukemia in first remission (n = 75), chronic myelocytic leukemia in chronic or accelerated phase (n = 48) or leukemia in advanced stage (n = 56) were given HLA-identical marrow grafts and randomized to receive methotrexate or cyclosporine for prevention of...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Storb R,Deeg HJ,Fisher L,Appelbaum F,Buckner CD,Bensinger W,Clift R,Doney K,Irle C,McGuffin R

    更新日期:1988-02-01 00:00:00

  • Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.

    abstract::Cutaneous T-cell lymphomas (CTCLs) primarily affect skin and are characterized by proliferation of mature CD4(+) T-helper cells. The pattern of cytokine production in the skin and blood is considered to be of major importance for the pathogenesis of CTCLs. Abnormal cytokine expression in CTCLs may be responsible for e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-590398

    authors: Geskin LJ,Viragova S,Stolz DB,Fuschiotti P

    更新日期:2015-04-30 00:00:00

  • Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: treatment of bone marrow cells with monoclonal antibody CT-2 and complement.

    abstract::Patients with congenital T lymphocyte deficiency disorders received transplants with parental bone marrow depleted of mature T cells by the use of an anti-T cell monoclonal antibody (CT-2) and complement. Our results with 16 consecutive patients (20 transplants) showed rapid engraftment of donor cells; cytoreduction (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moen RC,Horowitz SD,Sondel PM,Borcherding WR,Trigg ME,Billing R,Hong R

    更新日期:1987-09-01 00:00:00

  • Mechanisms of resistance to high and low linear energy transfer radiation in myeloid leukemia cells.

    abstract::Low linear energy transfer (LET) ionizing radiation (IR) is an important form of therapy for acute leukemias administered externally or as radioimmunotherapy. IR is also a potential source of DNA damage. High LET IR produces structurally different forms of DNA damage and has emerged as potential treatment of metastati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-404509

    authors: Haro KJ,Scott AC,Scheinberg DA

    更新日期:2012-09-06 00:00:00

  • Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells.

    abstract::Notch and its ligands have been implicated in the regulation and differentiation of various CD4(+) T-helper cells. Regulatory T cells (T(regs)), which express the transcription factor Foxp3, suppress aberrant immune responses that are typically associated with autoimmunity or excessive inflammation. Previous studies h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-144980

    authors: Samon JB,Champhekar A,Minter LM,Telfer JC,Miele L,Fauq A,Das P,Golde TE,Osborne BA

    更新日期:2008-09-01 00:00:00

  • Expression and regulation of chemokine receptors in human natural killer cells.

    abstract::Using flow cytometric and RNase protection assays, this study examined the expression of chemokine receptors in nonactivated natural killer (NK) cells and compared this expression with NK cells activated with interleukin (IL)-2, which either adhered to plastic flasks (AD) or did not adhere (NA). None of the NK cell su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.2.367

    authors: Inngjerdingen M,Damaj B,Maghazachi AA

    更新日期:2001-01-15 00:00:00

  • Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.

    abstract::Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by thrombotic microangiopathy leading to end-organ damage. The standard of care (SOC) treatment is therapeutic plasma exchange (TPE) alongside immunomodulation with steroids, with increasing use of rituximab +/- other immuno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006052

    authors: Goshua G,Sinha P,Hendrickson JE,Tormey CA,Bendapudi P,Lee AI

    更新日期:2020-12-06 00:00:00